Thanks, Pieter, 

 

Interesting.  As somebody who has followed the research, is it true that the 
matter simply stands with the Hah-vud studies retracted, and nothing more said? 
 That doesn’t seem right. 

 

Nick 

 

Nick Thompson

 <mailto:[email protected]> [email protected]

 <https://wordpress.clarku.edu/nthompson/> 
https://wordpress.clarku.edu/nthompson/

 

From: Friam <[email protected]> On Behalf Of Pieter Steenekamp
Sent: Thursday, May 6, 2021 1:12 PM
To: The Friday Morning Applied Complexity Coffee Group <[email protected]>
Subject: Re: [FRIAM] FW: Covid-Lancet-PART-2 (002).doc

 

I'm not particularly fond of Donald Trump, but the elephant in the room is that 
 Hydroxychloroquine became well-known after Trump advocated it. At the time I 
followed and researched it a bit and I came to the conclusion that both the 
mainstream media and the medical industry were against  Hydroxychloroquine 
mainly because Trump actively advocated it. The Lancet saga certainly did not 
influence me to change that conclusion.



 

On Thu, 6 May 2021 at 19:52, Frank Wimberly <[email protected] 
<mailto:[email protected]> > wrote:

This does not seem interesting to me.  The vaccines have been demonstrated to 
be effective and safe to very large degrees based on many millions of 
inoculations.  Why should I care about some suspect studies with small n.

---
Frank C. Wimberly
140 Calle Ojo Feliz, 
Santa Fe, NM 87505

505 670-9918
Santa Fe, NM

 

On Thu, May 6, 2021, 11:33 AM <[email protected] 
<mailto:[email protected]> > wrote:

Dear Phellow Phriammers, 

 

I have noted that most of what I have written here of late has been ignored, 
and that’s ok, actually.  Usually, it is the possibility that you MIGHT read 
what I write that keeps me writing and, behaviorist to the last, writing is 
what I need to do in order to think.  

 

But this situation is different.  I really don’t know what to think about 
Pavlovic’s <https://www.researchgate.net/profile/Dragan-Pavlovic-4>  paper.  
There may have been some trouble with the cloud version, so I have attached it 
to this message. 

 

So, this is a case where I really need some help.  I realize that you are all 
engaged in this excellent correspondence about UBI, which has revealed all 
sorts of “-ists” that I never thought were alive and well in the world, let 
alone in this group.  I would not interfere with that for a second.  But, could 
a few of you take a look at his paper 
<https://1drv.ms/w/s!AptIKbsAd7gjllccpq9yXXQ4hb2N?e=HCzjaV>   (very short, a 
commentary, actually).  I think he is actually a candidate for this group.  He 
is an MD, Phd, anaesthesiologist, retired in Paris, who has participated in 
hundreds of scientific papers,  who is passionate ( I worry, perhaps sometimes 
a bit too passionate) about dozens of different things and suspicious of 
everything. He wants, for instance, to dig a gigantic tunnel to bring large 
ships directly from the danube to the Mediterranean.   

 

I, of course, live in a bubble, but I don’t like to have that fact thrust in my 
face as powerfully as when he reveals to me that the two HAAA=VUD papers 
denouncing Chloquoroquine were retracted a year ago, and I never found out.  I 
can’t get any sense of whether there has been any attempt to revive them or to 
redo the original clinical study that suggested HCQ’s efficacy against CoVid.   

 

Any little bit of help you could give me would be great. 

 

Nick 

 

Nick Thompson

 <mailto:[email protected]> [email protected]

 <https://wordpress.clarku.edu/nthompson/> 
https://wordpress.clarku.edu/nthompson/

 

From: [email protected] <mailto:[email protected]>  
<[email protected] <mailto:[email protected]> > 
Sent: Wednesday, May 5, 2021 9:48 PM
To: 'The Friday Morning Applied Complexity Coffee Group' <[email protected] 
<mailto:[email protected]> >
Cc: 'Prof David West' <[email protected] <mailto:[email protected]> >
Subject: Covid-Lancet-PART-2 (002).doc

 

Dear Colleagues, 

 

I attach a paper <https://1drv.ms/w/s!AptIKbsAd7gjllccpq9yXXQ4hb2N?e=HCzjaV>  
written by an internet acquaintance I made some years back, Dragan Pavlovic.  I 
am sending it along for two reasons.  First, it reveals (to me, at least) that 
the two negative studies on Hydroxychloroquine use in SARS-CoVid-19 treatment 
were based on unverified data and were withdrawn by their authors almost 
immediately.  (Have the rest of you known this for the last year and not told 
me?  I cannot believe, after we pilloried poor Dave for advocating for it, that 
he has not gloated about it. ) Second, Pavlovic raises the intension/extension 
distinction in the context of the interpretation of scientific results and also 
questions Randomized Control Trials as the "Gold Standard" for discovery. Thus, 
I think he is a kindred spirit, being a bit of a grumpy contrarian like many of 
us here.  I have promised to forward any comments you make to him, so be polite 
but speak truth.   

 

Thanks, 

 

Nick Nicholas Thompson

Emeritus Professor of Ethology and Psychology

Clark University

[email protected] <mailto:[email protected]> 

https://wordpress.clarku.edu/nthompson/

 

 

 

 

 

 

- .... . -..-. . -. -.. -..-. .. ... -..-. .... . .-. .
FRIAM Applied Complexity Group listserv
Zoom Fridays 9:30a-12p Mtn GMT-6  bit.ly/virtualfriam 
<http://bit.ly/virtualfriam> 
un/subscribe http://redfish.com/mailman/listinfo/friam_redfish.com
FRIAM-COMIC http://friam-comic.blogspot.com/
archives: http://friam.471366.n2.nabble.com/

- .... . -..-. . -. -.. -..-. .. ... -..-. .... . .-. .
FRIAM Applied Complexity Group listserv
Zoom Fridays 9:30a-12p Mtn GMT-6  bit.ly/virtualfriam 
<http://bit.ly/virtualfriam> 
un/subscribe http://redfish.com/mailman/listinfo/friam_redfish.com
FRIAM-COMIC http://friam-comic.blogspot.com/
archives: http://friam.471366.n2.nabble.com/

- .... . -..-. . -. -.. -..-. .. ... -..-. .... . .-. .
FRIAM Applied Complexity Group listserv
Zoom Fridays 9:30a-12p Mtn GMT-6  bit.ly/virtualfriam
un/subscribe http://redfish.com/mailman/listinfo/friam_redfish.com
FRIAM-COMIC http://friam-comic.blogspot.com/
archives: http://friam.471366.n2.nabble.com/

Reply via email to